Pharmaceutical Commerce - January/February 2014

Walgreens' Pharma Dynamics subsidiary will be merged into CareMetx

HDMA's 2013-14 Factbook updates member financial, operational performance

New KoolTemp GTS parcels have higher performance and lower cost and weight

An inaugural planning meeting was held in November; meanwhile China cracks down on online sales

New 'emergent biopharma' service combines compliance with pricing, market access

The trend toward self-administered drugs creates a pressing need for better patient-education resources

PwC's annual forecast of the year's most important healthcare trends

The Health & Personal Care Logistics Conference brings industry leaders together

The Drug Quality and Security Act will change industry for the better

Will 'white bagging' and specialty-pharmacy business practices change distribution dynamics?

Growth includes 1-4% CAGR in US, 0-3% in Europe and 14-17% in China. US specialties have a twist

Both Revitas and Model N bring out enhanced script-validation modules to ensure rebate accuracy

New service launched by WEGO Health offers rapid feedback from key opinion influencers in consumer healthcare

Finance, marketing and other nontraditional users find value in the company's sales and inventory data

Liaison Healthcare Informatics predicts trends for healthcare and life sciences

Contract packager addresses growing clinical-products business

Analysts find that better adherence can be a competitive advantage in new-product introductions

Multichannel marketing is high in attention, but low on execution; Docnet will be a new social media platform

Long-awaited track-and-trace law ushers in a new era of pharmaceutical supply-chain monitoring; compounding pharmacies get a new structure also

Advanced label technologies serve functions far beyond product identification

Rising production and trade, along with tightening regulations, make life sciences an attractive target for air cargo and logistics services

Despite proven medical value, coupon and copay offset programs continue to draw fire from insurers; meanwhile, will the programs extend to ACA insureds?

The growing complexity of managed-markets contract support makes outsourcing a near-necessity for Small Pharma, and a better option for Big Pharma